Infections in Saudi Arabia: Where Are We Standing?

Overview

Journal Saudi Pharm J

Specialty Pharmacy

Date 2020 Sep 14

PMID 32922143

Citations 4

Authors

Najla A Obaid

Abdullah A Alhifany

Affiliations

Soon will be listed here.

Abstract

infections (CDIs) are infamous healthcare-associated infections for causing watery diarrhea to long-term hospitalized patients with a high mortality rate. Epidemiological reports from western countries showed up-trending pattern in the number of CDIs cases. It is becoming immensely challenging for routine diagnostic protocols to detect CDIs accurately with short turnaround time. In Saudi Arabia, there is a paucity of data about CDIs' prevalence, recurrence rate, methods of screening and mortality rate. Nevertheless, a growing number of cases with similar virulence strains and comparable antibiotic resistance pattern to the western countries counterparts reported data were also detected. This review aims to present the status of CDIs' diagnosis and incidence rate in Saudi Arabia based on current literature.

Citing Articles

Prevalence of toxigenic in hospitalized patients in the southwestern province of Saudi Arabia: Confirmation using the GeneXpert analysis.

Kameli N, Basode V, Abdulhaq A, Alamoudi M, Zain K, Ghzwani A Libyan J Med. 2023; 19(1):2294571.

PMID: 38112195 PMC: 11792808. DOI: 10.1080/19932820.2023.2294571.

Vancomycin vs metronidazole use for the treatment of infection in a tertiary care hospital in Saudi Arabia.

Alhameed A, Saferuddin N, Alturkistani T, Al Musawa M, Damfu N, Alattas M Heliyon. 2023; 9(11):e22053.

PMID: 38027991 PMC: 10663888. DOI: 10.1016/j.heliyon.2023.e22053.

Systematic Review and Meta-Analysis on the Frequency of Antibiotic-Resistant Species in Saudi Arabia.

Banawas S Antibiotics (Basel). 2022; 11(9).

PMID: 36139945 PMC: 9495114. DOI: 10.3390/antibiotics11091165.

Bacteraemia and Septic Arthritis in a Sickle Cell Disease Patient.

Alqurashi M, Madani B, Mursi M, Eltayeb N Eur J Case Rep Intern Med. 2022; 9(3):003243.

PMID: 35402324 PMC: 8988493. DOI: 10.12890/2022_003243.

Raw Animal Meats as Potential Sources of in Al-Jouf, Saudi Arabia.

Taha A Food Sci Anim Resour. 2021; 41(5):883-893.

PMID: 34632406 PMC: 8460330. DOI: 10.5851/kosfa.2021.e44.

References

Qutub M, Govindan P, Vattappillil A . Effectiveness of a Two-Step Testing Algorithm for Reliable and Cost-Effective Detection of Clostridium difficile Infection in a Tertiary Care Hospital in Saudi Arabia. Med Sci (Basel). 2019; 7(1). PMC: 6359226. DOI: 10.3390/medsci7010006. View

Wong K, Choi B, Fraser T, Donskey C, Deshpande A . Diagnostic testing methods for Clostridium difficile infection: A statewide survey of Ohio acute care hospitals. Am J Infect Control. 2016; 45(3):306-307. DOI: 10.1016/j.ajic.2016.09.007. View

Alzouby S, Baig K, AlRabiah F, Shibl A, Al-Nakhli D, Senok A . Clostridioides difficile infection: Incidence and risk factors in a tertiary care facility in Riyadh, Saudi Arabia. J Infect Public Health. 2019; 13(7):1012-1017. DOI: 10.1016/j.jiph.2019.10.014. View

Al-Tawfiq J, Abed M . Clostridium difficile-associated disease among patients in Dhahran, Saudi Arabia. Travel Med Infect Dis. 2010; 8(6):373-6. DOI: 10.1016/j.tmaid.2010.10.003. View

Senok A, Aldosari K, Alowaisheq R, Abid O, Alsuhaibani K, Khan M . Detection of antigen and toxin in stool specimens: Comparison of the quik chek complete enzyme immunoassay and GeneXpert polymerase chain reaction assay. Saudi J Gastroenterol. 2017; 23(4):259-262. PMC: 5539681. DOI: 10.4103/sjg.SJG_80_17. View

Burnham C, Carroll K . Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories. Clin Microbiol Rev. 2013; 26(3):604-30. PMC: 3719497. DOI: 10.1128/CMR.00016-13. View

Peng Z, Jin D, Kim H, Stratton C, Wu B, Tang Y . Update on Antimicrobial Resistance in Clostridium difficile: Resistance Mechanisms and Antimicrobial Susceptibility Testing. J Clin Microbiol. 2017; 55(7):1998-2008. PMC: 5483901. DOI: 10.1128/JCM.02250-16. View

Chitnis A, Holzbauer S, Belflower R, Winston L, Bamberg W, Lyons C . Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011. JAMA Intern Med. 2013; 173(14):1359-67. DOI: 10.1001/jamainternmed.2013.7056. View

Leffler D, Lamont J . Clostridium difficile infection. N Engl J Med. 2015; 372(16):1539-48. DOI: 10.1056/NEJMra1403772. View

10.

Alhifany A, Almutairi A, Almangour T, Shahbar A, Abraham I, Alessa M . Comparing the efficacy and safety of faecal microbiota transplantation with bezlotoxumab in reducing the risk of recurrent infections: a systematic review and Bayesian network meta-analysis of randomised controlled trials. BMJ Open. 2019; 9(11):e031145. PMC: 6858162. DOI: 10.1136/bmjopen-2019-031145. View

11.

Vonberg R, Kuijper E, Wilcox M, Barbut F, Tull P, Gastmeier P . Infection control measures to limit the spread of Clostridium difficile. Clin Microbiol Infect. 2008; 14 Suppl 5:2-20. DOI: 10.1111/j.1469-0691.2008.01992.x. View

12.

Alzahrani N, Al Johani S . Emergence of a highly resistant Clostridium difficile strain (NAP/BI/027) in a tertiary care center in Saudi Arabia. Ann Saudi Med. 2013; 33(2):198-9. PMC: 6078626. DOI: 10.5144/0256-4947.2013.198. View

13.

Al-Tawfiq J, Rabaan A, Bazzi A, Raza S, Noureen M . Clostridioides (Clostridium) difficile-associated disease: Epidemiology among patients in a general hospital in Saudi Arabia. Am J Infect Control. 2020; 48(10):1152-1157. DOI: 10.1016/j.ajic.2020.01.011. View

14.

Hall A, Curns A, McDonald L, Parashar U, Lopman B . The roles of Clostridium difficile and norovirus among gastroenteritis-associated deaths in the United States, 1999-2007. Clin Infect Dis. 2012; 55(2):216-23. DOI: 10.1093/cid/cis386. View

15.

Alcala L, Reigadas E, Marin M, Martin A, Catalan P, Bouza E . Impact of clinical awareness and diagnostic tests on the underdiagnosis of Clostridium difficile infection. Eur J Clin Microbiol Infect Dis. 2015; 34(8):1515-25. DOI: 10.1007/s10096-015-2380-3. View

16.

McDonald L, Gerding D, Johnson S, Bakken J, Carroll K, Coffin S . Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018; 66(7):e1-e48. PMC: 6018983. DOI: 10.1093/cid/cix1085. View

17.

Freeman J, Vernon J, Pilling S, Morris K, Nicholson S, Shearman S . The ClosER study: results from a three-year pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes, 2011-2014. Clin Microbiol Infect. 2017; 24(7):724-731. DOI: 10.1016/j.cmi.2017.10.008. View

18.

Aljafel N, Al-Shaikhy H, Alnahdi M, Thabit A . Incidence of Clostridioides difficile infection at a Saudi Tertiary Academic Medical Center and compliance with IDSA/SHEA, ACG, and ESCMID guidelines for treatment over a 10-year period. J Infect Public Health. 2020; 13(8):1156-1160. DOI: 10.1016/j.jiph.2020.03.007. View

19.

Fatima R, Aziz M . The Hypervirulent Strain of Clostridium Difficile: NAP1/B1/027 - A Brief Overview. Cureus. 2019; 11(1):e3977. PMC: 6440555. DOI: 10.7759/cureus.3977. View

20.

Truong C, Gombar S, Wilson R, Sundararajan G, Tekic N, Holubar M . Real-Time Electronic Tracking of Diarrheal Episodes and Laxative Therapy Enables Verification of Clostridium difficile Clinical Testing Criteria and Reduction of Clostridium difficile Infection Rates. J Clin Microbiol. 2017; 55(5):1276-1284. PMC: 5405247. DOI: 10.1128/JCM.02319-16. View